TABLE 6B.

Combined amyloid and tau positivity profiles.

	Full	Stable MCI		Reverters		False
	Sample	Unadjusted	Adjusted	Unadjusted	Adjusted	Reverters n = 18
A−T−
Count	39	22	27	17	12	5
Percent	17.3%	13.3%	14.7%	28.3%	28.6%	27.8%
A + T−
Count	42	26	32	16	10	6
Percent	18.5%	15.7%	17.4%	26.7%	23.8%	33.3%
A−T+
Count	27	20	23	7	4	3
Percent	11.9%	12.0%	12.5%	11.7%	9.5%	16.7%
A + T+
Count	118	98	102	20	16	4
Percent	52.2%	59.0%	55.4%	33.3%	38.1%	22.2%
A+ and/or T+
Count	187	144	157	43	30	13
Percent	82.7%	86.7%	85.3%	71.7%	71.4%	72.2%

Presents the number of participants (Count) and percent of sample (%) for combinations of cerebrospinal fluid biomarker positivity: biomarker-negative (A−/T−), amyloid-positive and tau-negative (A+/T−), amyloid-negative and tau-positive (A−/T+), amyloid and tau positive (A+/T+), and positive for any biomarker (A+ and/or T+).